Background: Alendronate (AL), a drug for inhibiting osteoclast-mediated boneresorption, was intercalated into an inorganic drug delivery nanovehicle, layered double hydroxide (LDH), to form a new nanohybrid, AL-LDH, with 1:1 heterostructure along the crystallographic C-axis. Based on the intercalation reaction strategy, the present AL-LDH drug delivery system (DDS) was realized with an enhanced drug efficacy of AL, which was confirmed by the improved proliferation and osteogenic differentiation of osteoblast-like cells (MG63). Methods: The AL-LDH nanohybrid was synthesized by conventional ion-exchange reaction and characterized by powder X-ray diffraction (PXRD), high-resolution transmission electron microscopy (HR-TEM), and Fourier transform infrared (FT-IR) spectroscopy. Additionally, in vitro efficacy tests, such as cell proliferation and alkaline phosphatase (ALP) activity, were analyzed. Results: The AL was successfully intercalated into LDH via ion-exchange reaction, and thus prepared AL-LDH DDS was X-ray single phasic and chemically well defined. The accumulated AL content in MG63 cells treated with the AL-LDH DDS nanoparticles was determined to be 10.6-fold higher than that within those treated with the intact AL after incubation for 1 hour, suggesting that intercellular permeation of AL was facilitated thanks to the hybridization with drug delivery vehicle, LDH. Furthermore, both in vitro proliferation level and ALP activity of MG63 treated with the present hybrid drug, AL-LDH, were found to be much more enhanced than those treated with the intact AL. This is surely due to the fact that LDH could deliver AL drug very efficiently, although LDH itself does not show any effect on proliferation and osteogenic differentiation of MG63 cells.
INTRODUCTION
Understanding intercellular uptake behavior of nanovehicles is an challenging research area of drug delivery, which has attracted great attention for improving therapeutic benefits of various bioactive molecules (drugs, peptides, proteins, and DNA, etc.), particularly those having some weakness such as difficulty and inefficiency crossing the cell membrane due to their enzymatic drug degradation, low circulation stability, and lack of target specificity. 1- 3 In the past few decades, many efforts have been made to design various inorganic nanovehicles to induce enhanced cellular uptake behavior based on the surface modification strategy for targeted delivery, low toxicity, and controlled release property. 4, 5 Among various inorganic delivery carriers, layered double hydroxide (LDH) has been suggested as a promising nanovehicle for the encapsulation and intercellular delivery of biological molecules. 6-8 In general, LDH, known as an anionic clay, is represented by a general chemical formula (M , and A n-are di-, tri-valent metal cations and interlayer anions, respectively. 9 The isomorphic substitutions of M 2+ with M 3+ in brucitelike layers give rise to the positive layer charge, and thus anionic species can be encapsulated in between layers of LDH in order to satisfy the charge neutrality condition. 10, 11 High anion exchange capacity (AEC) of LDH offers to intercalate various kinds of negatively charged bioactive molecules into the interlayer space of LDHs via simple co-precipitation or ion-exchange reactions, resulting in novel bio-inorganic nanohybrids. 12, 13 And at the same time, the positive surface charge of LDH enables easy approach and adhesion to cell membranes with negative charge inherently by electrostatic interactions without further chemical modifications. 14 Most importantly, it has been already confirmed that LDH nanovehicle with a size of around 100 nm could deliver bioactive molecules very efficiently through its unique cellular uptake mechanism, clathrin-mediated endocytosis. 15, 16 As compared to other inorganic nanovehicles, including silica and gold nanoparticles, quantum dots, and carbon nanotubes, LDH was proved to be highly advantageous due to its excellent biocompatibility, 17 high drug loading capacity 18 and pH-responsive property 19 with biodegradability in the cellular cytoplasm 16 and therefore, applicable as an efficient non-viral drug delivery vehicle and also as a reservoir for bioactive or bio-fragile molecules.
Alendronate (AL) itself has been clinically used to treat patients with diseases from osteoclast-mediated bone resorption such as bone metastasis, hypercalcemia of malignancy, post-menopausal osteoporosis and Paget's disease 20, 21 because it impedes bone resorption by selective uptake and absorption to divalent ions in bone due to its strong chelating molecular configuration with di-phosphates (P-O-P and P-C-P). 22 Moreover, it has been proved to not only inhibit osteoclastic bone resorption but also induce mineralization of newly formed bone by osteoblasts. 23- 25 However, AL has its intrinsic adverse effect such as low intracellular permeability, which in turn results in low drug efficacy. 26 It is, therefore, highly required to find an appropriate delivery vehicle for AL to overcome such a drawback. As appeared in the literature, 27 there was only one trial related to the intercalation reaction of AL into LDH vehicle, however, all the samples were neither X-ray single phasic nor chemically defined, due to the fact that the intercalation reaction could not reach to an equilibrium. 27 In the present study, an attempt has been made to enhance the cellular uptake efficacy of AL, an anti-resorptive and bone-remodeling drug, by encapsulating it into the drug delivery vehicle (LDH), to form a drug-LDH nanohybrid (i.e., AL-LDH) with two-dimensional heterostructure. In this respect, we intended to prepare X-ray single phasic AL-LDH considering various parameters in the reaction solution such as pH, concentration of AL, and AEC of LDH. To the best of our knowledge, this is the first study to examine the cellular uptake efficacy of single phasic AL-LDH structurally and chemically well-defined on the proliferation and osteogenic differentiation of human osteoblast-like cells (MG63). 3 ), the equal volumes of FITC (5 mg/mL) and Zn 2 Al_CO 3 LDH (5 mg/mL) were mixed together, followed by stirring for 12 hours. The resulting precipitate was washed 5 times with DI water to remove the excess FITC and freeze-dried.
METHODS

Materials
Characterizations
Powder X-ray diffraction (PXRD) patterns were measured with a diffractometer (D/MAXRINT 2200-Ultima, Rigaku, Japan) equipped with Ni-filtered Cu-Kα radiation (λ = 1.5418 Å). The high-resolution transmission electron microscopy (HR-TEM) image of AL-LDH was obtained with a JEM-2100F (JEOL, Tokyo, Japan), which was operated at an accelerating voltage of 200 kV. Fourier transform infrared (FT-IR) spectra were measured with a JASCO 6100 spectrophotometer (JASCO, Tokyo, Japan) with a potassium bromide disk pellet method. Field emission scanning electron microscopy (FE-SEM) images were measured with a JSM-6700F (JEOL). The size distribution and surface charge were recorded using Nano ZS (Malvern, UK). 
In vitro drug release test
To examine in vitro drug release profile, the AL-LDH particles were suspended in 900 mL of pH 7.4 phosphate-buffered saline (PBS) at 37°C and continuously stirred at 125 rpm using a dissolution apparatus 2 (paddle type, Vision ® G2 Elite 8TM Dissolution Tester, Hanson, MA, USA). At a scheduled time for 100 days, 3 mL of the medium was collected and the same amount of fresh PBS was added back. The sampled medium was filtered with Nylon syringe filter (0.45 μm pore, Merck Millipore), which was added to the FeCl 3 standard solution to quantitatively measure the released amount of AL out of AL-LDH using UV-Vis spectrophotometer. At least three batches of samples were tested for statistics.
In vitro study
MG63 cells (Korean Cell Line Bank) were grown in DMEM medium supplemented with 10% heat inactivated fetal bovine serum, 100 units/mL penicillin, and 100 µg/mL streptomycin under a 5% CO 2 atmosphere with 95% humidity at 37°C. When the cells grew up to 80%-90% confluence, they were isolated from cell culture dishes by trypsinization and washed with 10 mM DPBS.
Quantification of accumulated AL in MG63 cells
MG63 cells seeded on a 60 mm culture dish at 2.0 × 10 6 cells per well were treated with intact AL or AL-LDH containing at the equivalent concentration of AL (50 µg/mL). After the given incubation time for 1, 2, 4, 6, 12, and 24 hours, the cells were washed two times with DPBS, harvested by trypsin-EDTA treatment, and separated by centrifugation. After the precipitated pellets were washed twice with DPBS, 5 mL of cell lysis buffer (20 mM Tris-HCl, pH 7.5, 1% Triton X-100, 150 mM NaCl, and 1 mM EDTA) was added and the pellets were incubated on ice for 20 minutes followed by ultrasonication (Sonics & Materials Inc., Newtown, CT, USA) for 20 seconds. After centrifuging the crude cell lysates at 10,000 rpm for 5 minutes, 10 mL acetonitrile (DAEJUNG, Siheung, Korea) was added to the cell supernatants, and the resulting mixture was vigorously vortexed to precipitate proteins. After further centrifugation of the mixture at 10,000 rpm for 3 minutes, 20 mL chloroform (DAEJUNG) was added to the supernatant to remove lipids, which was then collected by centrifugation at 2,000 rpm for 10 minutes. The final supernatant was added to the FeCl 3 standard solution to measure the concentration of AL using UV-Vis spectrophotometer. Each experiment was repeated at least three times. 
Confocal laser scanning microscopy (CLSM) study
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incubated at 37°C and 5% CO 2 for 24 hours. Then, the medium in the well was replaced by the FITC-LDH-CO 3 suspension (20 µg/mL) in fresh medium and incubated under the same condition. A control experiment was also performed with intact FITC (20 µg/mL) and the centrifugal supernatant of the FITC-LDH-CO 3 suspended in the cell medium under the same conditions. After incubation for 1 hour, the cells were washed three times with DPBS and fresh cell medium were then added to the plates. For the staining of nucleus, 140 µL of NucBlue (Live Cell Stain ReadyProbes ® reagent; Thermo Fisher Scientific, Waltham, MA, USA) was added and incubated for additional 20 minutes at 25°C. The stained cells were imaged under a confocal laser scanning microscope (Leica TCS SP8 STED CW; Leica Microsystems Inc., Buffalo Grove, IL, USA) equipped with both DAPI filter (Ex. 420 nm/Em. 460 nm) and FITC filter (Ex. 495 nm/Em. 520 nm). The obtained images were processed using Leica LASAF software.
Proliferation study
The MG63 cells were seeded onto 96-well plates at 2 × 10 4 cells per well and incubated at 37°C under a 5% CO 2 atmosphere for 24 hours. Then, the cell medium in each well was completely substituted with osteogenic medium (2 mM L-glutamine, 10 mM β-glycerophosphate, and 50 ng/mL L-ascorbic added to cell media) containing pristine LDH (Zn 2 Al_NO 3 LDH), intact AL, or AL-LDH, and the cells were cultured for 2, 3, or 4 days. At every predetermined time, the cells were washed with DPBS, and the cell proliferation was assessed with CCK-8, following the manufacturer's instruction. 29 Briefly, 100 μL CCK-8 solution was added into each well and cultured for additional 3 hours and then the optical density of each well was measured at 450 nm on a microplate reader (Multiskan FC, Thermo Fisher Scientific), and expressed in percentage based on the optical density of negative control (only osteogenic medium was treated to the cells). The assay was performed at least three times for statistics.
Alkaline phosphatase (ALP) activity
MG63 cells were cultured in 6-well plates at 1.5 × 10 5 cells per well and incubated overnight at 37°C under a 5% CO 2 atmosphere for 24 hours. The cell medium in each well of the plate was completely substituted with the osteogenic medium containing pristine LDH (Zn 2 Al_ NO 3 LDH), intact AL, or AL-LDH and treated under the same conditions described above. At a given time, the adherent cells were scraped off and suspended in 3 mL of osteogenic medium, which was shaken at 4°C for 10 minutes and centrifuged at 2,500 rpm for 10 minutes. The supernatant (50 μL) was then transferred to 96-well plate and the same volume of PNPP solution was added. 23 The total amounts of released enzyme from the cells were spectrophotometrically measured by a microplate reader (Multiskan FC, Thermo Fisher Scientific) at 405 nm. At least three times were tested for each sample type.
Statistical analysis
All data for in vitro cell proliferation and ALP activity was applied in one-way ANOVA with α = 0.05 followed by pairwise comparisons using a Tukey's post hoc test (Prism, version 5.01; GraphPad, San Diego, CA, USA). P < 0.05 was considered statistically significant.
RESULTS
PXRD analysis
In the previous work, 27 an attempt was made to intercalate AL into LDH, but failed to prepare chemically well-defined AL-LDH nanohybrid. According to the PXRD analysis, no X-ray Fig. 1 ), AL may exist in the forms of AL 2-= 0.49, AL 3-= 0.49, and AL 4-= 0.02 at pH 10.9, in which primary amine group in AL could be considered to be almost deprotonated. Thus, we set the pH of solution at 10.9 in order for the intercalative ionexchange reaction of AL into LDH not to be disturbed by protonated primary amine in AL.
A 2.5-fold excess amount of AL was reacted with the carbonate type of Mg 2 Al-LDH (Mg 2 Al_ CO 3 LDH) and the nitrate type (Mg 2 Al_NO 3 LDH), respectively, at pH 10.9. As shown in Supplementary Fig. 2A and B, the AL molecules were not successfully intercalated into both LDHs. The XRD patterns of Mg 2 Al_CO 3 LDH remained unchanged with respect to the reaction time, indicating that no intercalation of AL into LDH occurred. In the case of Mg 2 Al_NO 3 LDH, however, the intercalation reaction could be observed, but resulted in the formation of two phases, AL intercalated LDH and unreacted Mg 2 Al_NO 3 LDH, within 24 hours. On the other hand, a single phasic AL-LDH was realized, when the nitrate type of Zn 2 Al_NO 3 LDH was intercalated as shown in Supplementary Fig. 2C . Though the AL intercalated LDH was coexisted with the unreacted within the reaction time of 8 hours, the intercalation reaction of AL into the Zn 2 Al_ NO 3 LDH was reached to an equilibrium beyond 12 hours, where well-ordered (00l) reflections could be observed for AL-Zn 2 Al_NO 3 LDH (abbreviated as AL-LDH).
As shown in Fig. 1A , the basal spacing was expanded to 11.3 Å from 8.7 Å (that of Zn 2 Al_ NO 3 LDH) upon intercalation of AL. The gallery height of AL-LDH was estimated to be 6.5 Å (11.3 Å -4.8 Å [the thickness of LDH single layer]), which was smaller than the molecular dimension of AL as shown in Supplementary Fig. 3A and B. It is, therefore, expected that AL molecules were likely to be stabilized with a monolayer arrangement as shown in Supplementary Fig. 3C . ). In the range of A e > A c , the guest molecules could be incorporated between the LDH layers with parallel monolayer orientation along the ab plane of LDH.
In order to gain further insight in the arrangement of intercalated AL molecules in the interlayer space of LDH, we compared the relative intensity (I rel ) of the observed X-ray intensity (I obs ) to that of the calculated one (I cal ) from the structural models of AL-LDH ( Supplementary Fig. 4A-C) . The structure factor (F[00l]) of the each structural model was obtained from the atomic scattering factor for each atom in the unit cell (f i ) and the position of atoms (z i ) along c-axis based on the following equation,
. 30 The integrated intensity of (00l) diffraction peak (I[00l]) was proportional to the square of F(00l) and to Taking into account of steric limitation between the intercalated AL molecules and the positively charged sites of LDH layer, the basal spacing of AL-LDH, and the molecular dimension of AL, three structural models of AL-LDH could be suggested as follows; 1) two phosphate groups of AL molecule were electrostatically interacted with up and down sides of LDH layers as shown in Supplementary Fig. 4A , and 2) two phosphate groups of AL molecule were electrostatically interacted with only one side (up or down side) of LDH layer as shown in Supplementary Fig. 4B and C. Although it was not easy to refine the interlayer structure of AL-LDH due to the limited number of (00l) diffractions, the interlayer structure of AL-LDH in Supplementary Fig. 4C would be highly probable among those three models: the I cal values from the model were close to the I obs values, as shown in Supplementary Fig. 4D .
HR-TEM study
From the cross-sectional HR-TEM image of AL-LDH as shown in Fig. 1B , well-ordered 2D structure of AL-LDH could be confirmed. The distance between the lattice fringes along the crystallographic C-axis was observed to be approximately 11.3 Å, which was in excellent agreement with the d 00l value obtained from the PXRD pattern.
FT-IR analysis
The FT-IR spectrum of AL-LDH was compared to those of intact AL and pristine LDH (Zn 2 Al_ NO 3 LDH) (Fig. 2) . For intact AL, the characteristic infrared vibration bands, such as O-H of phosphate (3,490 cm 
2D Inorganic Nanovector and Its Alendronate Derivative
(00 ) = � cos (2 ) =0 AL molecules through the intercalative ion-exchange reaction. The broad peak between 1,800 and 2,700 cm -1 corresponding to the O-H stretching absorption in the O = P-OH group of AL, 33 was disappeared in AL-LDH due to the deprotonation of OH groups, which were electrostatically interacted with the LDH layers.
Particle size and surface charge studies
According to the field emission scanning electron microscopy (FE-SEM) images (Fig. 3A  and B) , the plate-like LDH particles with an average size of around 120 nm were not that changed upon intercalation of AL to form AL-LDH, indicating that the intercalation reaction proceeded without any structural reconstruction, but went on topotactically. According to the dynamic light scattering (DLS) analysis (Fig. 3C) , the particle sizes were measured to be 118 ± 13 nm and 120 ± 11 nm for the pristine LDH and AL-LDH, respectively, which were in good agreement with the FE-SEM data. Furthermore, as shown in Fig. 3D , the surface charge of pristine LDH was determined to be 35.1 ± 0.1 mV, but such a distinctive positive surface charge became reduced to 0.3 ± 0.15 mV upon intercalation of AL, due to the strong electrostatic interaction between the negatively charged AL and positively charged LDH layer.
UV-Vis spectroscopy
The AL content in the AL-LDH was determined through UV-Vis spectrophotometric analysis using FeCl 3 -AL complexes were recorded in the wavelength range of 200-400 nm (Supplementary Fig. 5A ). As expected, no UV absorbance appeared for intact AL and AL-LDH, but the absorption peaks with λ max for the Fe 3+ standard and Fe 3+ -AL complexes were clearly observed. The absorbances of Fe 3+ -AL complexes were read at 300 nm depending on the concentrations of AL in order to obtain a calibration curve of AL (Supplementary Fig. 5B ).
On the basis of calibration curve, the AL content in AL-LDH was determined to be 26.5%, which was in excellent agreement with the theoretical one (26.3%). Briefly, the latter was 
In vitro release test
According to the in vitro cumulative AL release profile from AL-LDH as shown in Fig. 4 , the AL molecules seemed to be hardly deintercalated under the condition of the PBS solution pH of 7.4 at 37°C. At the initial stage, prevalent anions in PBS, such as anionic forms of phosphate and chloride, facilitated the desorption of AL molecules on the external surface of the AL-LDH nanoparticles, resulting in the initial burst (5%) of AL. After 2 days, however, another 4.5% of AL in the interlayer space of LDH was very slowly released out until 100 days. More than 90% of AL molecules were thermodynamically stabilized in the 2D lattice, and eventually remained as the AL-LDH hybrid, due to the strong electrostatic interaction between deprotonated AL molecules and positively charged LDH lattice.
As described in the structural model of AL-LDH (Supplementary Fig. 6A ), the deprotonated phosphate group of AL bound to only one side of LDH layer by strong electrostatic interaction, resulting in the controlled release of AL from AL-LDH. One other possible explanation for that might be the zipping effect of layered edges bonded with small anions present in the PBS solution, and therefore, AL molecules can be locked up there in the interlayer space of LDH, giving rise to the retarded out-diffusion from AL-LDH (Supplementary Fig. 6B ). 34 In order to rationalize the release behavior of AL from AL-LDH depending on the above assumptions, the observed release profile of AL-LDH was fitted to four kinetic models as shown in Supplementary Fig. 7 and the obtained rate constants (k d ) and r 2 values were summarized in Supplementary Table 1 . The first-order kinetic model, describing dissolution phenomena, was not an option to be considered due to the poor r 2 value (0.66), indicating that the release of AL from AL-LDH does not mainly depend on the dissolution determined process. 34 In contrast, the parabolic diffusion model, which is a modified Freundlich model, and Elovich one were well fitted to the observed release profile of AL with reliable r 2 values of more than 0.95. It is, therefore, suggested that the AL release process is a kind of diffusioncontrolled process or heterogeneous diffusion processes. 34 
Cellular uptake studies
In order to verify efficient cellular uptake behavior of LDH, we quantified the accumulated concentration of AL in MG63 cells with respect to incubation time. As shown in Fig. 5 , MG63 cells treated with the AL-LDH nanoparticles exhibited 10.6 times higher intracellular accumulation of AL than those treated with intact AL at the 1hour incubation time, indicating that LDH, as a delivery vehicle, could facilitate permeation of AL into MG63 cells. Such an improved uptake efficacy of AL with LDH was greatly superior to that with other AL delivery systems, such as chitosan coated polyethylene oxide microsphere and chitosan coated liposome, which showed only 3-fold and 2-fold increases, respectively. 29 The concentration of AL in MG63 cells treated with AL-LDH was rapidly increased up to 11.16 µg/mL within 1 hour, but gradually decreased with time. Throughout all incubation periods, AL-LDH exhibited much higher intracellular uptake efficacy than intact AL. As expected, intact AL cannot easily be permeated inside the cells due to repulsive interaction between the negatively charged cell membrane and anionic AL molecules. On the other hand, the positive layer charge of LDH became mostly neutralized upon intercalation of anionic AL to form AL-LDH with a slightly positive charge, which can electrostatically interact with the cellular membranes, leading to favorable cellular uptake based on clathrin-mediated endocytosis. 15 It is, therefore, concluded that LDH could play a role as an efficient drug delivery carrier.
To trace intercellular pathway of LDH visually, the LDH-CO 3 nanoparticles were conjugated with a dye, FITC, to form FITC-LDH-CO 3 , which was then incubated in MG63 cell culture line and its permeation behaviour was studied by the CLSM as shown in Supplementary Fig. 8 and Supplementary Fig. 9 . The green fluorescence was observed throughout the cytoplasm of MG63 cells cultured with 20 µg/mL of FITC-LDH-CO 3 for 1 hour (Supplementary Fig. 10A ). On the contrary, the green fluorescence was not detected within cells in the control experiments ( Supplementary Fig. 10B and C) , which was carried out with the centrifugal supernatant of FITC-LDH-CO 3 and intact FITC solution, respectively. And it became clear that the green fluorescence within cells was not from free FITC, but from the uptake of the FITC-LDH-CO 3 nanoparticles
In vitro cell proliferation and ALP activity
To assess the drug-carrier efficacy, we also investigated the effects of AL-LDH on the cell proliferation and osteogenic differentiation in the MG63 cell culture line, which was compared to those of intact AL and pristine LDH. And the cells treated with the osteogenic medium only were employed as the control.
In vitro proliferation level of MG63 cells was investigated on the basis of colorimetric CCK-8 assay, which has been widely used for determining the cell viability in terms of cell proliferation and cytotoxicity. 29 As shown in Supplementary Fig. 11 , both intact AL and AL-LDH showed higher cell proliferation in all concentrations of AL during the whole tested period than the pristine LDH. One thing to note here was that the cells incubated with AL-LDH gave rise to an enhanced cell proliferation compared to intact AL in all conditions. As shown in Fig. 6 , the highest cell proliferation was observed at the concentration of 1 × 10 −8
M AL for both intact AL and AL-LDH, which were 29.8% and 59.8%, respectively, above the negative control value. However, no increase in cell proliferation could be observed for the pristine LDH. The cell proliferation for all the samples tested was either increased or maintained even after 2 day incubation, indicating that AL-LDH and the pristine LDH were not cytotoxic, which could be also supported by our previous studies. The efficacy of cell differentiation was also evaluated for AL-LDH together with intact AL in terms of ALP activity, which has been widely used as a marker for early differentiation of osteoblast-like cells to demonstrate improved osteogenic activity. 23 As can be seen in Supplementary Fig. 12 , both intact AL and AL-LDH showed higher ALP activities of MG63 cells than pristine. In particular, the ALP activities on the day 3 and 4 were significantly increased for the cells treated with intact AL only at the concentration of 10 −8 M AL. On the other hand, AL-LDH exhibited statistically significant difference in ALP activity at any given concentrations of AL during whole tested periods as compared to the pristine LDH and the negative control (P < 0.05). As shown in Fig. 7 , the highest increases in ALP activity of MG63 cells relative to that of negative control group were 12.4% and 29.1% at the concentration of 10 -8 M AL of intact AL and AL-LDH, respectively. Additionally, ALP activity did not appear to change substantially with pristine LDH or the control at all concentrations. When the same dose of AL was applied, both the in vitro cell proliferation and the ALP activity for AL-LDH were more efficiently improved than those for intact AL, which could be ascribed to the facilitated intercellular uptake of AL-LDH; unlike negatively charged AL molecules, the positive zeta potential (0.3 ± 0.15 mV) of AL-LDH nanoparticles led to an enhanced interaction with negatively charged cellular membranes, eventually resulting in favorable cellular uptake based on clathrin-mediated endocytosis. 8, 15 Although the pristine LDH itself did not show any effect on the cell proliferation and osteogenic differentiation, the AL intercalated LDH nanohybrid could be considered as a novel drug delivery system (DDS) for improving efficacy of AL.
DISCUSSION
A novel DDS, Al-LDH, was prepared by intercalating AL, one of nitrogen-containing bisphosphonate drug, into LDH nanovehicle. The purpose of this study was not only to suggest the synthetic way of AL-LDH hybrid drug, but to provide the proof of concept, how the LDH delivery vehicle could improve the drug efficacy of AL in terms of the proliferation and osteogenic differentiation on the MG63 cell culture line.
We were successful in establishing the synthetic condition of the hybrid drug, AL-LDH, based on the intercalative ion-exchange reaction, where 2.5-fold excess amount of AL was reacted with the pristine LDH taking into account the AEC of LDH. Since the solution pH could affect on intercalation of AL molecules into LDH due to amphiprotic nature of AL. Thus, we carefully controlled the pH during the reaction based on pKa values of AL (pKa 1 , 0.8; pKa 2 , 2.2; pKa 3 , 6.3; pKa 4 , 10.9; and pKa 5 , 12.2). According to the PXRD and HR-TEM analyses, the basal spacing of AL-LDH nanohybrid was determined to be 11.3 Å, corresponding to the sum of the layer thickness (4.8 Å) and the van der Waal's diameter (6.5 Å) of AL molecule with parallel orientation. From the in vitro release test, it was found that AL molecules intercalated were rather strongly bound with LDH lattice, and therefore, hardly released out. And the total amount of AL released from Al-LDH was only about to 9.5% after 100 days. According to the cellular uptake studies, the intracellular accumulation of AL in MG63 cells treated with AL-LDH was 10.6-fold higher than that with intact AL for 1 hour treatment. From the CLSM images, the internalization of LDH nanoparticles was confirmed by the localization of green fluorescence within cells due to the intercellular uptake of FITC-LDH-CO 3 itself. Furthermore, in vitro cell proliferation and ALP activity results showed that the incorporation of AL into LDH could enhance efficacy of AL compared to intact AL, although LDH itself had no effect on proliferation and osteogenic differentiation of MG63 cells.
In conclusion, the present AL-LDH could be considered as a promising DDS for improving efficacy of AL.
SUPPLEMENTARY MATERIALS
Supplementary Table 1 Evaluated rate constants and r 2 coefficients based on the kinetic models
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